This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
07/29/15 - 3:59:08 PM ET (BATS BZX Real-time Price)
Div Yield: --
AEZS Day's Range
AEZS 52 Week Range
AEZS Business Summary
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health.View AEZS key stats
AEterna Zentaris Inc - AEZS - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates AEterna Zentaris Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate AETERNA ZENTARIS INC (AEZS) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.